.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Accenture
Healthtrust
Harvard Business School
Boehringer Ingelheim
McKinsey
Moodys
Deloitte
Daiichi Sankyo

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,366,600

« Back to Dashboard

Which drugs does patent 8,366,600 protect, and when does it expire?


Patent 8,366,600 protects ZECUITY and is included in one NDA.

This patent has nineteen patent family members in eleven countries.

Summary for Patent: 8,366,600

Title:Polyamine enhanced formulations for triptan compound iontophoresis
Abstract: A patch and compositions for iontophoresis of triptan compounds are described.
Inventor(s): Sebree; Terri B. (Gladwyne, PA), Horstmann; Michael (Neuwied, DE), Sameti; Mohammad (Bonn, DE)
Assignee: NuPathe Inc. (Conshohocken, PA)
Application Number:12/214,555
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Teva Branded Pharm
ZECUITY
sumatriptan succinate
SYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF, USING A FLOWABLE HYDROGEL FORMULATION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,366,600

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2008358026► Subscribe
Australia2015224400► Subscribe
Canada2727926► Subscribe
China102065807► Subscribe
China104027885► Subscribe
Eurasian Patent Organization023339► Subscribe
Eurasian Patent Organization026988► Subscribe
Eurasian Patent Organization201100055► Subscribe
Eurasian Patent Organization201590907► Subscribe
European Patent Office2296597► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Baxter
Harvard Business School
Deloitte
Healthtrust
Dow
Cipla
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot